Eduardo Muñoz

18PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesTraditional Chinese medicine and treatmentsInfant and child healthMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 10, 2025
Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome.

Francisco J Ponce-Díaz, Francisco Ruiz-Pino, Martín Garrido-Rodriguez

|Nov 02, 2024
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Sonia Burgaz, Elisa Navarro, Santiago Rodríguez-Carreiro

|Mar 28, 2024
AMPK Activation by Cimicifuga racemosa Extract Ze 450 Is Associated with Metabolic Effects and Cellular Resilience against Age-Related Pathologies in Different Tissue Cell Types.

Madeline Günther, Peter Schnierle, Thorsten Rose

|Sep 28, 2023
The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.

Santiago Rodríguez-Carreiro, Elisa Navarro, Eduardo Muñoz

|Dec 23, 2022
Neuroprotective Effects of Betulinic Acid Hydroxamate in Intraventricular Hemorrhage-Induced Brain Damage in Immature Rats.

Aarón Del Pozo, Laura Silva, Angela Romero

|Aug 26, 2022
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.

Diego Caprioglio, Hawraz Ibrahim M Amin, Orazio Taglialatela-Scafati

Pageof 3

Frequent Collaborators

6 joint publications

Javier Fernández-Ruiz

2 joint publications

Diego Caprioglio

2 joint publications

Orazio Taglialatela-Scafati

1 joint publications

Isabel González-Mariscal